The presence of TP53 mutations often correlates with a poorer prognosis in several types of cancer. This is because TP53 mutations are associated with more aggressive tumor behavior, increased resistance to chemotherapy and radiation, and a higher likelihood of recurrence. Therefore, detecting TP53 mutations can provide valuable prognostic information and help guide treatment strategies.
